Download this letter from the pdf link
http://www.fda.gov/medwatch/safety/2006/paroxetineDHCPMay06.pdf
Please note that GSK findings included suicidality risk raised in adults aged18-30 with
"NON-DEPRESSIVE CONDITIONS" as well as those with depressive conditions.
Ergo: the suicidality was NOT caused by depression as it affected people both with and without depression when given seroxat / aropax / paxil.